| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | 64 | 4.907 | 0 | 34.870 | 160.926 | 88.315 | 142.964 |
| Total Income - EUR | - | - | - | 245 | 6.184 | 8.580 | 35.233 | 163.882 | 92.203 | 143.385 |
| Total Expenses - EUR | - | - | - | 57.236 | 43.469 | 42.803 | 19.252 | 52.186 | 66.654 | 96.147 |
| Gross Profit/Loss - EUR | - | - | - | -56.991 | -37.285 | -34.223 | 15.981 | 111.696 | 25.550 | 47.238 |
| Net Profit/Loss - EUR | - | - | - | -56.992 | -37.340 | -34.224 | 15.633 | 107.448 | 21.091 | 43.592 |
| Employees | - | - | - | 1 | 1 | 1 | 1 | 0 | 0 | 1 |
Check the financial reports for the company - Biomax Technology S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | 0 | 114 | 77.086 | 76.345 | 76.558 | 75.392 | 74.894 |
| Current Assets | - | - | - | 91.704 | 109.382 | 23.150 | 47.375 | 160.036 | 185.374 | 95.711 |
| Inventories | - | - | - | 89.792 | 88.854 | 12.283 | 12.011 | 10.375 | 12.012 | 42.433 |
| Receivables | - | - | - | 1.733 | 10.678 | 9.102 | 2.625 | 14.044 | 173.311 | 44.598 |
| Cash | - | - | - | 179 | 9.850 | 1.765 | 32.740 | 135.617 | 52 | 8.679 |
| Shareholders Funds | - | - | - | -56.347 | -92.527 | -124.997 | -106.593 | 524 | 21.614 | 65.085 |
| Social Capital | - | - | - | 645 | 702 | 688 | 673 | 675 | 673 | 669 |
| Debts | - | - | - | 150.750 | 202.022 | 225.233 | 230.313 | 236.069 | 239.153 | 105.520 |
| Income in Advance | - | - | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "3821 - 3821" | |||||||||
| CAEN Financial Year |
3821
|
|||||||||
Comments - Biomax Technology S.r.l.